Fast recovery with etanercept in patients affected by polymyalgia rheumatica and decompensated diabetes : a case-series study
We enrolled nine consecutive patients affected by newly diagnosed polymyalgia rheumatica and decompensated diabetes mellitus. All patients were treated with etanercept (25 mg twice weekly) and prednisone and were followed up to 1 year. At the sixth-month follow-up, etanercept and prednisone were withdrawn. Patients were seen at regular intervals (days 0, 30, 60, 90, 150, 180) and the following variables determined: erythrocytes sedimentation rate, C-reactive protein, fasting serum glucose, pain measured by visual analog scale, and the Health Assessment Questionnaire. Our results indicate that etanercept might have some steroid-sparing effects, but controlled investigations are needed to support etanercept use in clinical practice for this kind of patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2009 |
---|---|
Erschienen: |
2009 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
Clinical rheumatology - 28(2009), 1 vom: 19. Jan., Seite 89-92 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Corrao, Salvatore [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antirheumatic Agents |
---|
Anmerkungen: |
Date Completed 26.02.2009 Date Revised 13.11.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s10067-008-1026-6 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM183922786 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM183922786 | ||
003 | DE-627 | ||
005 | 20231223165615.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2009 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10067-008-1026-6 |2 doi | |
028 | 5 | 2 | |a pubmed24n0613.xml |
035 | |a (DE-627)NLM183922786 | ||
035 | |a (NLM)18946712 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Corrao, Salvatore |e verfasserin |4 aut | |
245 | 1 | 0 | |a Fast recovery with etanercept in patients affected by polymyalgia rheumatica and decompensated diabetes |b a case-series study |
264 | 1 | |c 2009 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.02.2009 | ||
500 | |a Date Revised 13.11.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a We enrolled nine consecutive patients affected by newly diagnosed polymyalgia rheumatica and decompensated diabetes mellitus. All patients were treated with etanercept (25 mg twice weekly) and prednisone and were followed up to 1 year. At the sixth-month follow-up, etanercept and prednisone were withdrawn. Patients were seen at regular intervals (days 0, 30, 60, 90, 150, 180) and the following variables determined: erythrocytes sedimentation rate, C-reactive protein, fasting serum glucose, pain measured by visual analog scale, and the Health Assessment Questionnaire. Our results indicate that etanercept might have some steroid-sparing effects, but controlled investigations are needed to support etanercept use in clinical practice for this kind of patients | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Antirheumatic Agents |2 NLM | |
650 | 7 | |a Hypoglycemic Agents |2 NLM | |
650 | 7 | |a Immunoglobulin G |2 NLM | |
650 | 7 | |a Insulin |2 NLM | |
650 | 7 | |a Receptors, Tumor Necrosis Factor |2 NLM | |
650 | 7 | |a Etanercept |2 NLM | |
650 | 7 | |a OP401G7OJC |2 NLM | |
650 | 7 | |a Prednisone |2 NLM | |
650 | 7 | |a VB0R961HZT |2 NLM | |
700 | 1 | |a Pistone, Giovanni |e verfasserin |4 aut | |
700 | 1 | |a Scaglione, Rosario |e verfasserin |4 aut | |
700 | 1 | |a Colomba, Daniela |e verfasserin |4 aut | |
700 | 1 | |a Calvo, Luigi |e verfasserin |4 aut | |
700 | 1 | |a Licata, Giuseppe |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical rheumatology |d 1987 |g 28(2009), 1 vom: 19. Jan., Seite 89-92 |w (DE-627)NLM012613037 |x 1434-9949 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2009 |g number:1 |g day:19 |g month:01 |g pages:89-92 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10067-008-1026-6 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 28 |j 2009 |e 1 |b 19 |c 01 |h 89-92 |